Constellation Pharmaceuticals Archives -

Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges

Synthetic control arms in clinical trials: Making it happen

https://pharmaphorum.com/webinars/synthetic-control-arms-in-clinical-trials-making-it-happen/

Shares in German biotech MorphoSys have gone on the slide after it announced a $1.7 billion deal to

MorphoSys offers $1.7bn for Constellation, but investors see stars

https://pharmaphorum.com/news/morphosys-offers-1-7bn-for-constellation-but-investors-see-stars/

US biotech Epizyme is gearing up for a potentially lucrative second indication for its Tazverik (tazemetostat), after the

Epizyme eyes lucrative use for newly-launched Tazverik

https://pharmaphorum.com/news/epizyme-eyes-lucrative-use-for-newly-launched-tazverik/

Constellation Pharmaceuticals